Search Results - "Donis, N."

Targeting of C‐type lectin‐like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides: reply by Delierneux, C., Donis, N., Servais, L., Wéra, O., Lancellotti, P., Oury, C.

“…We provide here a new set of data supporting the involvement of multiple platelet receptors in CpG ODN platelet activating effects. We observed some…”
Get full text

Targeting of C‐type lectin‐like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides by Delierneux, C., Donis, N., Servais, L., Wéra, O., Lecut, C., Vandereyken, M., Musumeci, L., Rahmouni, S., Schneider, J., Eble, J. A., Lancellotti, P., Oury, C.

“…Essentials CpG oligodeoxynucleotide (ODN) immuotherapeutics cause undesired platelet activating effects. It is crucial to understand the mechanisms of these…”
Get full text

524P Cell line study of nucleosome-based biomarkers in the diagnosis and detection of relapses in glioblastoma by Decarpentrie, J., Van den Ackerveken, P., Govaerts, A., Lobbens, A., Beine, E., Donis, N., Herzog, M., Douxfils, J.

Get full text

Effect of cholesterol- and palm oil-enriched diets on rabbit aorta and aortic valve calcification by Donis, N., D’emal, C., Hulin, A., Gustin, M., Dulgheru, R.E., Lancellotti, P., Oury, C.

Get full text

Targeting of C-type lectin-like receptorￂ 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides by Delierneux, C, Donis, N, Servais, L, Wera, O, Lecut, C, Vandereyken, M, Musumeci, L, Rahmouni, S, Schneider, J, Eble, J A, Lancellotti, P, Oury, C

“…Essentials CpG oligodeoxynucleotide (ODN) immuotherapeutics cause undesired platelet activating effects. It is crucial to understand the mechanisms of these…”
Get full text